nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—CYP3A4—bone cancer	0.623	1	CbGaD
Olanzapine—HTR1B—dura mater—bone cancer	0.0198	0.134	CbGeAlD
Olanzapine—HTR1D—dura mater—bone cancer	0.0192	0.13	CbGeAlD
Olanzapine—DRD5—eyelid—bone cancer	0.0189	0.128	CbGeAlD
Olanzapine—HTR1B—trigeminal nerve—bone cancer	0.00853	0.0577	CbGeAlD
Olanzapine—HTR1D—trigeminal nerve—bone cancer	0.00825	0.0559	CbGeAlD
Olanzapine—HTR3A—cranial nerve—bone cancer	0.00724	0.049	CbGeAlD
Olanzapine—ORM1—vertebral column—bone cancer	0.00636	0.043	CbGeAlD
Olanzapine—HRH1—nose—bone cancer	0.00626	0.0423	CbGeAlD
Olanzapine—HTR1B—cranial nerve—bone cancer	0.00608	0.0411	CbGeAlD
Olanzapine—HTR1D—cranial nerve—bone cancer	0.00588	0.0398	CbGeAlD
Olanzapine—HTR7—cranial nerve—bone cancer	0.00469	0.0317	CbGeAlD
Olanzapine—HTR2A—trigeminal nerve—bone cancer	0.0041	0.0278	CbGeAlD
Olanzapine—HRH4—bone marrow—bone cancer	0.00302	0.0204	CbGeAlD
Olanzapine—HTR2A—cranial nerve—bone cancer	0.00292	0.0198	CbGeAlD
Olanzapine—HTR2A—vertebral column—bone cancer	0.00287	0.0194	CbGeAlD
Olanzapine—HTR2A—hindlimb—bone cancer	0.00246	0.0167	CbGeAlD
Olanzapine—HTR2A—appendage—bone cancer	0.00211	0.0143	CbGeAlD
Olanzapine—H1F0—connective tissue—bone cancer	0.00157	0.0106	CbGeAlD
Olanzapine—HTR1D—connective tissue—bone cancer	0.00121	0.00821	CbGeAlD
Olanzapine—H1F0—tendon—bone cancer	0.00108	0.00729	CbGeAlD
Olanzapine—H1F0—bone marrow—bone cancer	0.00104	0.00706	CbGeAlD
Olanzapine—H1F0—spinal cord—bone cancer	0.00104	0.00703	CbGeAlD
Olanzapine—HTR7—connective tissue—bone cancer	0.000967	0.00654	CbGeAlD
Olanzapine—ORM1—bone marrow—bone cancer	0.00089	0.00603	CbGeAlD
Olanzapine—ORM1—spinal cord—bone cancer	0.000886	0.006	CbGeAlD
Olanzapine—HTR1B—spinal cord—bone cancer	0.000831	0.00562	CbGeAlD
Olanzapine—HTR2C—spinal cord—bone cancer	0.000797	0.00539	CbGeAlD
Olanzapine—HTR2B—tendon—bone cancer	0.000776	0.00525	CbGeAlD
Olanzapine—HRH1—connective tissue—bone cancer	0.000722	0.00489	CbGeAlD
Olanzapine—ADRA2A—connective tissue—bone cancer	0.000709	0.0048	CbGeAlD
Olanzapine—HTR1A—spinal cord—bone cancer	0.000671	0.00454	CbGeAlD
Olanzapine—HTR7—tendon—bone cancer	0.000665	0.0045	CbGeAlD
Olanzapine—HTR7—spinal cord—bone cancer	0.000641	0.00434	CbGeAlD
Olanzapine—ADRA2C—tendon—bone cancer	0.000611	0.00413	CbGeAlD
Olanzapine—HTR2A—connective tissue—bone cancer	0.000603	0.00408	CbGeAlD
Olanzapine—ADRA2C—spinal cord—bone cancer	0.000589	0.00399	CbGeAlD
Olanzapine—HRH1—tendon—bone cancer	0.000496	0.00336	CbGeAlD
Olanzapine—ADRA2A—tendon—bone cancer	0.000487	0.0033	CbGeAlD
Olanzapine—ADRA2A—spinal cord—bone cancer	0.00047	0.00318	CbGeAlD
Olanzapine—HTR2A—tendon—bone cancer	0.000414	0.0028	CbGeAlD
Olanzapine—HTR2A—spinal cord—bone cancer	0.0004	0.0027	CbGeAlD
Olanzapine—ABCB1—bone marrow—bone cancer	0.000263	0.00178	CbGeAlD
Olanzapine—ABCB1—spinal cord—bone cancer	0.000262	0.00177	CbGeAlD
Olanzapine—DRD4—Signaling Pathways—KIT—bone cancer	2.53e-05	0.00011	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—TP53—bone cancer	2.53e-05	0.00011	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.52e-05	0.00011	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—KIT—bone cancer	2.5e-05	0.000109	CbGpPWpGaD
Olanzapine—ALB—Metabolism—CYP3A4—bone cancer	2.49e-05	0.000109	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—BRAF—bone cancer	2.49e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—BRAF—bone cancer	2.49e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	2.48e-05	0.000108	CbGpPWpGaD
Olanzapine—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.48e-05	0.000108	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFBR2—bone cancer	2.48e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—BRAF—bone cancer	2.47e-05	0.000108	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	2.47e-05	0.000108	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GNA11—bone cancer	2.47e-05	0.000108	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFBR2—bone cancer	2.46e-05	0.000107	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	2.44e-05	0.000106	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	2.43e-05	0.000106	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—DHFR—bone cancer	2.43e-05	0.000106	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—BRAF—bone cancer	2.42e-05	0.000105	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—KIT—bone cancer	2.42e-05	0.000105	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—EGFR—bone cancer	2.42e-05	0.000105	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—EGFR—bone cancer	2.41e-05	0.000105	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GNA11—bone cancer	2.41e-05	0.000105	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—DHFR—bone cancer	2.41e-05	0.000105	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—EGFR—bone cancer	2.4e-05	0.000104	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—EGFR—bone cancer	2.4e-05	0.000104	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—KIT—bone cancer	2.39e-05	0.000104	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—BRAF—bone cancer	2.38e-05	0.000104	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IGF1R—bone cancer	2.38e-05	0.000103	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—JUN—bone cancer	2.37e-05	0.000103	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—JUN—bone cancer	2.35e-05	0.000102	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—BRAF—bone cancer	2.35e-05	0.000102	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—EGFR—bone cancer	2.35e-05	0.000102	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IGF1R—bone cancer	2.34e-05	0.000102	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IGF1R—bone cancer	2.33e-05	0.000102	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IGF1R—bone cancer	2.32e-05	0.000101	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IGF1R—bone cancer	2.32e-05	0.000101	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—EGFR—bone cancer	2.31e-05	0.000101	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—MMP9—bone cancer	2.3e-05	0.0001	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IGF1R—bone cancer	2.29e-05	9.99e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	2.29e-05	9.97e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—MMP9—bone cancer	2.29e-05	9.96e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—KIT—bone cancer	2.28e-05	9.94e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—EGFR—bone cancer	2.28e-05	9.92e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—BRAF—bone cancer	2.27e-05	9.9e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GNA11—bone cancer	2.27e-05	9.89e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	2.26e-05	9.84e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GNA11—bone cancer	2.25e-05	9.81e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—KIT—bone cancer	2.25e-05	9.8e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—BRAF—bone cancer	2.25e-05	9.8e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—CYP3A4—bone cancer	2.24e-05	9.75e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.23e-05	9.7e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ENO2—bone cancer	2.22e-05	9.66e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—EGFR—bone cancer	2.2e-05	9.6e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—CYP3A4—bone cancer	2.19e-05	9.52e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—EGFR—bone cancer	2.18e-05	9.5e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—BRAF—bone cancer	2.14e-05	9.34e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—GSTP1—bone cancer	2.13e-05	9.29e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	2.13e-05	9.26e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—BRAF—bone cancer	2.12e-05	9.22e-05	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—EGFR—bone cancer	2.09e-05	9.09e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MDM2—bone cancer	2.09e-05	9.09e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MDM2—bone cancer	2.09e-05	9.08e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—EGFR—bone cancer	2.08e-05	9.05e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MDM2—bone cancer	2.07e-05	9.02e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CYP3A4—bone cancer	2.06e-05	8.97e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—DHFR—bone cancer	2.06e-05	8.97e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—TP53—bone cancer	2.06e-05	8.95e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—EGFR—bone cancer	2.05e-05	8.93e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CYP3A4—bone cancer	2.04e-05	8.89e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KIT—bone cancer	2.03e-05	8.85e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.03e-05	8.84e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MDM2—bone cancer	2.03e-05	8.83e-05	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—TP53—bone cancer	2.01e-05	8.77e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MDM2—bone cancer	2e-05	8.69e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MDM2—bone cancer	1.97e-05	8.58e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KIT—bone cancer	1.96e-05	8.54e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KIT—bone cancer	1.95e-05	8.5e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GNA11—bone cancer	1.92e-05	8.38e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GSTP1—bone cancer	1.92e-05	8.34e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.91e-05	8.32e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MDM2—bone cancer	1.91e-05	8.3e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KIT—bone cancer	1.9e-05	8.27e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MDM2—bone cancer	1.89e-05	8.21e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GSTP1—bone cancer	1.87e-05	8.14e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KIT—bone cancer	1.87e-05	8.14e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—EGFR—bone cancer	1.86e-05	8.1e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.85e-05	8.06e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—EGFR—bone cancer	1.85e-05	8.05e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—BRAF—bone cancer	1.84e-05	8.03e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—BRAF—bone cancer	1.83e-05	7.99e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—JUN—bone cancer	1.81e-05	7.9e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—JUN—bone cancer	1.81e-05	7.89e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—JUN—bone cancer	1.8e-05	7.84e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MDM2—bone cancer	1.8e-05	7.83e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.79e-05	7.78e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—BRAF—bone cancer	1.78e-05	7.77e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.78e-05	7.74e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MDM2—bone cancer	1.77e-05	7.72e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MMP9—bone cancer	1.77e-05	7.69e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MMP9—bone cancer	1.76e-05	7.68e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—JUN—bone cancer	1.76e-05	7.68e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GSTP1—bone cancer	1.76e-05	7.67e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.76e-05	7.65e-05	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—TP53—bone cancer	1.75e-05	7.64e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MMP9—bone cancer	1.75e-05	7.63e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GSTP1—bone cancer	1.75e-05	7.6e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.74e-05	7.6e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.74e-05	7.56e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—JUN—bone cancer	1.74e-05	7.56e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.73e-05	7.53e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PTGS2—bone cancer	1.72e-05	7.51e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KIT—bone cancer	1.72e-05	7.5e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MMP9—bone cancer	1.72e-05	7.47e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ENO2—bone cancer	1.71e-05	7.46e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—JUN—bone cancer	1.71e-05	7.45e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.7e-05	7.41e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KIT—bone cancer	1.7e-05	7.38e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KIT—bone cancer	1.69e-05	7.37e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MMP9—bone cancer	1.69e-05	7.35e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KIT—bone cancer	1.69e-05	7.34e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KIT—bone cancer	1.68e-05	7.32e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MMP9—bone cancer	1.67e-05	7.25e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KIT—bone cancer	1.66e-05	7.25e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KIT—bone cancer	1.66e-05	7.23e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—JUN—bone cancer	1.66e-05	7.21e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—JUN—bone cancer	1.64e-05	7.14e-05	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—TP53—bone cancer	1.62e-05	7.06e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—BRAF—bone cancer	1.62e-05	7.05e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MMP9—bone cancer	1.61e-05	7.02e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.6e-05	6.97e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MMP9—bone cancer	1.59e-05	6.94e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—BRAF—bone cancer	1.59e-05	6.94e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—BRAF—bone cancer	1.59e-05	6.92e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—DHFR—bone cancer	1.59e-05	6.92e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—BRAF—bone cancer	1.58e-05	6.9e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—BRAF—bone cancer	1.58e-05	6.88e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—EGFR—bone cancer	1.57e-05	6.83e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—BRAF—bone cancer	1.56e-05	6.81e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—JUN—bone cancer	1.56e-05	6.8e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—TP53—bone cancer	1.56e-05	6.8e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.56e-05	6.79e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—TP53—bone cancer	1.55e-05	6.76e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MDM2—bone cancer	1.55e-05	6.73e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.54e-05	6.73e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KIT—bone cancer	1.54e-05	6.72e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—JUN—bone cancer	1.54e-05	6.71e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—EGFR—bone cancer	1.54e-05	6.71e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MDM2—bone cancer	1.54e-05	6.69e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—EGFR—bone cancer	1.54e-05	6.69e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—EGFR—bone cancer	1.53e-05	6.67e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PTGS2—bone cancer	1.53e-05	6.65e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MMP9—bone cancer	1.52e-05	6.62e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.52e-05	6.6e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.51e-05	6.58e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MMP9—bone cancer	1.5e-05	6.53e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MDM2—bone cancer	1.5e-05	6.51e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GSTP1—bone cancer	1.49e-05	6.5e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GNA11—bone cancer	1.49e-05	6.47e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.47e-05	6.41e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.45e-05	6.31e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—EGFR—bone cancer	1.43e-05	6.21e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—EGFR—bone cancer	1.43e-05	6.21e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—EGFR—bone cancer	1.42e-05	6.17e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.41e-05	6.12e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PTGS2—bone cancer	1.4e-05	6.1e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—JUN—bone cancer	1.39e-05	6.06e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—EGFR—bone cancer	1.39e-05	6.04e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—EGFR—bone cancer	1.36e-05	5.94e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MDM2—bone cancer	1.36e-05	5.91e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.35e-05	5.89e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—EGFR—bone cancer	1.35e-05	5.86e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—JUN—bone cancer	1.34e-05	5.85e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—JUN—bone cancer	1.34e-05	5.82e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MDM2—bone cancer	1.34e-05	5.81e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MDM2—bone cancer	1.33e-05	5.8e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MDM2—bone cancer	1.33e-05	5.78e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MDM2—bone cancer	1.32e-05	5.76e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MDM2—bone cancer	1.31e-05	5.71e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.31e-05	5.69e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MMP9—bone cancer	1.31e-05	5.69e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—EGFR—bone cancer	1.3e-05	5.67e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MMP9—bone cancer	1.3e-05	5.66e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—JUN—bone cancer	1.3e-05	5.66e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—EGFR—bone cancer	1.29e-05	5.61e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—JUN—bone cancer	1.28e-05	5.57e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MMP9—bone cancer	1.26e-05	5.51e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MMP9—bone cancer	1.24e-05	5.42e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—EGFR—bone cancer	1.23e-05	5.35e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MDM2—bone cancer	1.21e-05	5.29e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—EGFR—bone cancer	1.21e-05	5.28e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TP53—bone cancer	1.2e-05	5.22e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TP53—bone cancer	1.2e-05	5.21e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TP53—bone cancer	1.19e-05	5.18e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—JUN—bone cancer	1.18e-05	5.14e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TP53—bone cancer	1.16e-05	5.07e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—JUN—bone cancer	1.16e-05	5.05e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—JUN—bone cancer	1.16e-05	5.04e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—JUN—bone cancer	1.15e-05	5.03e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTP1—bone cancer	1.15e-05	5.01e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—JUN—bone cancer	1.15e-05	5.01e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MMP9—bone cancer	1.15e-05	5e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TP53—bone cancer	1.15e-05	4.99e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—JUN—bone cancer	1.14e-05	4.96e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—JUN—bone cancer	1.14e-05	4.95e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TP53—bone cancer	1.13e-05	4.92e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MMP9—bone cancer	1.13e-05	4.92e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MMP9—bone cancer	1.13e-05	4.91e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MMP9—bone cancer	1.12e-05	4.89e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MMP9—bone cancer	1.12e-05	4.87e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—bone cancer	1.11e-05	4.83e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—bone cancer	1.11e-05	4.81e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTGS2—bone cancer	1.11e-05	4.81e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EGFR—bone cancer	1.09e-05	4.76e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—bone cancer	1.09e-05	4.76e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—bone cancer	1.08e-05	4.71e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—bone cancer	1.06e-05	4.6e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—JUN—bone cancer	1.06e-05	4.6e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—bone cancer	1.05e-05	4.57e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—bone cancer	1.03e-05	4.49e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—bone cancer	1.03e-05	4.47e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—bone cancer	1.02e-05	4.45e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—bone cancer	1.02e-05	4.43e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—bone cancer	1.01e-05	4.38e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—bone cancer	9.92e-06	4.32e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—bone cancer	9.68e-06	4.22e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—bone cancer	9.27e-06	4.04e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—bone cancer	9.19e-06	4e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—bone cancer	9.13e-06	3.97e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—bone cancer	9.12e-06	3.97e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—bone cancer	9.1e-06	3.96e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—bone cancer	9.07e-06	3.95e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—bone cancer	9.05e-06	3.94e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—bone cancer	9.05e-06	3.94e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—bone cancer	8.96e-06	3.9e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—bone cancer	8.93e-06	3.89e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—bone cancer	8.87e-06	3.86e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—bone cancer	8.82e-06	3.84e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—bone cancer	8.58e-06	3.74e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—bone cancer	8.44e-06	3.68e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—bone cancer	8.3e-06	3.61e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—bone cancer	7.79e-06	3.39e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—bone cancer	7.73e-06	3.37e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—bone cancer	7.66e-06	3.34e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—bone cancer	7.64e-06	3.33e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—bone cancer	7.62e-06	3.32e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—bone cancer	7.6e-06	3.31e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—bone cancer	7.52e-06	3.28e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—bone cancer	7.5e-06	3.27e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—bone cancer	6.97e-06	3.03e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—bone cancer	5.97e-06	2.6e-05	CbGpPWpGaD
